AI assistant
Sending…
SELLAS Life Sciences Group, Inc. — Director's Dealing 2013
Dec 17, 2013
33651_dirs_2013-12-16_63baa717-cd93-4dc6-90a3-115246e708ce.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Galena Biopharma, Inc. (GALE)
CIK: 0001390478
Period of Report: 2013-11-07
Reporting Person: HAMILTON BRIAN L (EVP & Chief Medical Officer)
More from SELLAS Life Sciences Group, Inc.
Regulatory Filings
2026
Jun 2
Report Publication Announcement
2026
May 12
Interim / Quarterly Report
2026
May 12
Major Shareholding Notification
2026
Mar 27
Capital/Financing Update
2026
Mar 20
Major Shareholding Notification
2026
Jan 30
Director's Dealing
2026
Jan 9
Director's Dealing
2026
Jan 9
Director's Dealing
2026
Jan 9
Director's Dealing
2026
Jan 9